Table 6. Reported perforation rates with ERCP.

Study	Length of Study	Number of ERCP's	Perforations	Operations	Mortality	Year
Chaudhary and Aranya [31]	10 years	750	10(1.3)	10(100%)	2(20%)	1996
Loperfido et al [6]	2 years	3356	28(0.83%)	10(35.7%)	4(14.3%)	1998
Stapfer et al [11]	5 years	1413	14(0.99%)	9(64.3%)	2(14.3%)	2000
Preetha et al [28]	9 years	4030	18(0.45%)	18(100%)	3(16.7%)	2003
Christensen et al [32]	2 years	1177	13(1.1%)	2(15.4%)	1(7.7%)	2004
Wu et al [33]	6 years	6620	30(0.45%)	10(33.3%)	5(16.7%)	2006
Fatima et al [18]	11 years	12427	76(0.6%)	22(28.9%)	5(6.6%)	2007
Cotton et al [4]	12 years	11497	16(0.14%)	11(68.8%)	1(6.3%)	2009
Morgan et al [34]	13 years	12817	24(0.2%)	10(41.7%)	1(4.2%)	2009
Gurung et al [35]	2 years	423	1(0.2%)	1(100%)	0 (0%)	2014
Katsinelos et al [36]	7 years	2837	3(0.11%)	1(0.035)	0 (0%)	2014
Present Series	6 years	2972	28(0.94%)	20(71.4%)	2 (7.1%)	2014

Footnotes: ERCP: Endoscopic Retrograde Cholangiopancreatography.